REGN

How is REGN doing right now?

In plain terms: REGN is 34.2% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

Right now REGN — Regeneron Pharmaceuticals — is in a deep drawdown, down 34.2% from its record high. Last price: $784.36. Asset price action of this severity has historically marked attractive entry zones — but only when fundamentals weren't permanently impaired. The historical median return below quantifies that pattern for REGN specifically.

What history says at this drawdown

Across all available history, REGN has spent enough trading days in the 35%-to-30% drawdown band to build a large sample (498 observations). Dipsern segments these by drawdown depth and computes the rolling median forward 90-day return — that median is the primary signal you see in the full app, and it's substantially more robust than mean-based forecasts because it ignores fat-tail outliers in both directions.

What this means for REGN

For US large-caps, drawdowns of 20-30% are typically driven by macro repricing (rates, earnings, sector rotation). Single-name 50%+ drawdowns are usually structural — the signal alone won't tell you which, but the segments table will show whether prior episodes recovered. Below 20% drawdowns the historical median forward return often becomes attractive — but with rising variance. The win-rate column in the segments table is more useful than the median at this depth.